Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More
Xconomy
AUGUST 5, 2016
—Gene therapy news: After investing in Bamboo Therapeutics and its Duchenne muscular dystrophy treatment earlier this year, Pfizer bought the Chapel Hill, NC-based biotech outright on Monday for $150 million up front , with potentially another $495 million later. . Regeneron is paying $25 million upfront.
40 
Let's personalize your content